These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21603994)

  • 1. Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects.
    Jereczek-Fossa BA; Rondi E; Zarowski A; D'Onofrio A; Alterio D; Ciocca M; Bianchi LC; Krengli M; Calabrese L; Ansarin M; Giugliano G; Orecchia R
    Strahlenther Onkol; 2011 Jun; 187(6):350-6. PubMed ID: 21603994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
    Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss.
    Lamers-Kuijper E; Schwarz M; Rasch C; Mijnheer B
    Med Dosim; 2007; 32(4):237-45. PubMed ID: 17980823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent unilateral hearing loss after radiotherapy for parotid gland tumors.
    van der Putten L; de Bree R; Plukker JT; Langendijk JA; Smits C; Burlage FR; Leemans CR
    Head Neck; 2006 Oct; 28(10):902-8. PubMed ID: 16783830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
    Kam MK; Chau RM; Suen J; Choi PH; Teo PM
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):145-57. PubMed ID: 12694833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
    Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late effects of radiotherapy on hearing.
    Schot LJ; Hilgers FJ; Keus RB; Schouwenburg PF; Dreschler WA
    Eur Arch Otorhinolaryngol; 1992; 249(6):305-8. PubMed ID: 1418938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
    Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy.
    Moeller BJ; Chintagumpala M; Philip JJ; Grosshans DR; McAleer MF; Woo SY; Gidley PW; Vats TS; Mahajan A
    Radiat Oncol; 2011 Jun; 6():58. PubMed ID: 21635776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
    Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
    Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abdominal DIBH reduces the cardiac dose even further: a prospective analysis.
    Zhao F; Shen J; Lu Z; Luo Y; Yao G; Bu L; Ge J; Yang X; Ning L; Yan S
    Radiat Oncol; 2018 Jun; 13(1):116. PubMed ID: 29929560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
    Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
    Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective longitudinal study on radiation-induced hearing loss.
    Anteunis LJ; Wanders SL; Hendriks JJ; Langendijk JA; Manni JJ; de Jong JM
    Am J Surg; 1994 Nov; 168(5):408-11. PubMed ID: 7977961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric evaluation of the skin-sparing effects of 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for left breast cancer.
    Jo IY; Kim SW; Son SH
    Oncotarget; 2017 Jan; 8(2):3059-3063. PubMed ID: 27997358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer.
    Kupelian PA; Reddy CA; Carlson TP; Altsman KA; Willoughby TR
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):904-12. PubMed ID: 12095556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.